Dendritic Cells Archive - Seite 46 von 107 - IOZK

Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM).

2015-06-17/in Dendritic Cells, Glioblastoma, International Publications /von 2015-06-17 / J Clin Oncol 33, 2015 (suppl; abstr e13030)

Brain Tumor Immunotherapy: What have We Learned so Far?

2015-06-17/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-06-17 / Front Oncol 2015;5:98

Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model

2015-06-13/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-32

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

2015-06-02/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2015-06-02 / Front Immunol 2015;6:271

Comparative impact of treatment on clinical benefit in patients with glioblastoma (GBM) enrolled in the phase II trial of ICT-107.

2015-06-01/in Dendritic Cells, Glioblastoma, International Publications /von 2015-06-01 / J Clin Oncol 33, 2015 (suppl; abstr 2036)

Phase III multicenter trial of eltrapuldencel-T: Autologous dendritic cells loaded with irradiated autologous tumor cells (DC-TC) in granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with metastatic melanoma (INTUS trial).

2015-06-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2015-06-01 / J Clin Oncol 33, 2015 (suppl; abstr TPS9082)

Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine.

2015-05-30/in Acute Leukemia, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 7007)

Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer.

2015-05-30/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr TPS5070)

Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.

2015-05-30/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 3048)

A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.

2015-05-29/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-05-29 / J Clin Oncol 33, 2015 (suppl; abstr e14033)